Immune Dysregulation in Lyme Disease
Persistent symptoms may involve altered immune signaling
Neuroinflammation can affect cognition, pain, and autonomic function
Persistent infection, coinfections, and post-infectious mechanisms may overlap
Immune dysregulation is increasingly recognized as one biologically plausible explanation for persistent symptoms after Lyme disease. Rather than reflecting a simply weakened or overactive immune system, altered immune signaling may contribute to fatigue, brain fog, pain, autonomic dysfunction, sleep disturbance, and gastrointestinal symptoms in some patients.
These symptoms are often misunderstood or minimized. Increasingly, researchers are examining how immune dysregulation and neuroinflammation may influence nervous system function long after the initial infection has been treated. In some patients, clinicians must also consider persistent Borrelia burgdorferi infection, other tick-borne coinfections, treatment effects, and unrelated medical conditions. These possibilities are not necessarily mutually exclusive.
This article explains how immune dysregulation may contribute to persistent symptoms in Lyme disease and how it connects the neurologic, autonomic, and organ-system dysfunctions discussed elsewhere on this site, including neuroinflammation, cytokine signaling, and post-infectious immune imbalance.
For a broader clinical framework on how Lyme disease may become chronic, see Preventing Chronic Lyme Disease.
Why symptoms can persist after Lyme disease
In most infections, the immune system activates, responds to the threat, and then down-regulates. In some patients with Lyme disease, this resolution phase may be incomplete or delayed.
Instead of returning fully to baseline, immune signaling may remain altered. This can result in ongoing inflammatory messaging, heightened sensitivity within the nervous system, and impaired physiologic regulation, even when there are no clear laboratory markers of active infection.
Immune dysregulation is only one possible explanation. Persistent symptoms may also be associated with ongoing or recurrent Borrelia burgdorferi infection, other tick-borne coinfections, persistent antigenic stimulation, tissue injury, autonomic dysfunction, central sensitization, or other medical conditions. The relative contribution of these mechanisms may vary among patients.
This pattern does not necessarily imply ongoing tissue damage, psychological distress, or irreversible injury. It may reflect dysregulation of immune signaling rather than immune failure or immune excess alone.
What immune dysregulation means in Lyme disease
Immune dysregulation refers to impaired control of immune signaling rather than a single abnormal laboratory value or diagnosis.
In Lyme disease, this may include prolonged or inappropriate cytokine signaling, difficulty terminating inflammatory responses, shifts between immune activation and immune exhaustion, and altered communication between the immune system and the nervous system.
Importantly, immune dysregulation does not require persistently abnormal blood tests. Many immune processes occur intermittently, locally, or below standard detection thresholds. This may help explain why some patients experience significant symptoms even when routine laboratory results appear reassuring.
Does Lyme disease weaken the immune system?
Lyme disease does not necessarily weaken the immune system in the same way that chemotherapy, advanced HIV infection, or certain immunosuppressive medications can. A patient with Lyme disease is not automatically immunocompromised.
Instead, Lyme disease may alter immune regulation in some patients. The immune response may become poorly coordinated, remain activated longer than expected, or fail to return completely to its previous baseline.
This distinction is important. An immune system can be dysregulated without being globally weak. Altered immune signaling may contribute to persistent inflammation, neuroimmune symptoms, autonomic instability, or fluctuating symptoms without producing the recurrent opportunistic infections typically associated with severe immune suppression.
What are the symptoms of immune dysregulation after Lyme disease?
There is no single symptom pattern or laboratory test that confirms immune dysregulation. Symptoms depend on which immune, neurologic, autonomic, and organ-system pathways are affected.
Symptoms associated with immune dysregulation after Lyme disease may include fatigue, brain fog, slowed processing speed, disrupted sleep, widespread pain, heightened sensory sensitivity, dizziness, orthostatic intolerance, exercise intolerance, gastrointestinal dysfunction, temperature dysregulation, and symptoms that worsen after physical or emotional stress.
These symptoms are not specific to immune dysregulation or Lyme disease. Other infectious, inflammatory, endocrine, neurologic, cardiovascular, psychiatric, sleep-related, and medication-related causes should be considered when clinically appropriate.
Neuroinflammation and immune dysregulation in Lyme disease
The immune system and nervous system are tightly interconnected. Cytokines and other immune mediators can influence brain function, autonomic control centers, pain-processing pathways, sleep regulation, and sensory processing.
When immune signaling remains dysregulated, the brain and nervous system may remain in a heightened or unstable state. This process, often referred to as neuroinflammation, may alter cognition, sleep regulation, sensory processing, and autonomic balance.
Neuroinflammation may help explain symptoms such as brain fog, slowed processing speed, heightened pain sensitivity, disrupted sleep architecture, and increased sensitivity to physical or emotional stress. These effects may reflect altered signaling and regulation rather than structural brain injury.
For a focused discussion of cognitive effects, see Brain Fog and Cognitive Dysfunction in Lyme Disease.
Immune–autonomic interaction
Immune dysregulation may also affect the autonomic nervous system, which helps regulate heart rate, blood pressure, digestion, temperature control, sweating, and sleep–wake cycles.
Inflammatory signaling may destabilize autonomic balance and interfere with the nervous system’s ability to transition into a restorative parasympathetic state. As a result, patients may experience orthostatic intolerance, fatigue disproportionate to exertion, gastrointestinal slowing, temperature dysregulation, palpitations, and non-restorative sleep.
This interaction provides a possible mechanistic bridge between immune signaling and Dysautonomia in Lyme Disease, which explains how loss of autonomic regulation can produce multisystem symptoms.
Why symptoms fluctuate
A hallmark of immune and autonomic dysregulation is variability. Symptoms may worsen during periods of physiologic stress, intercurrent infection, poor sleep, emotional strain, hormonal change, or physical overexertion.
These fluctuations do not always indicate disease progression or a new infection. They may reflect state-dependent changes in immune and nervous system signaling. However, a significant or sustained change in symptoms should not automatically be attributed to immune dysregulation without considering relapse, reinfection, coinfection, medication effects, or another medical condition.
Good days and bad days can occur without a clear external trigger, adding to patient frustration and diagnostic uncertainty. Understanding this variability helps explain why symptoms may appear inconsistent while remaining biologically grounded.
Immune dysregulation and pain amplification
Persistent immune signaling may sensitize pain pathways within the central nervous system, lowering thresholds for pain perception and amplifying otherwise normal sensory input.
This mechanism may help explain widespread pain, allodynia, hyperalgesia, and fluctuating pain intensity in some patients with Lyme disease, even when imaging studies and standard laboratory testing are unrevealing.
For a more detailed discussion of altered pain processing, see Pain Processing and Central Sensitization in Lyme Disease.
Immune dysregulation and gastrointestinal dysfunction
The gastrointestinal tract is highly responsive to both immune and autonomic signaling. When immune dysregulation contributes to autonomic dysfunction, gut motility and coordination may slow or become erratic.
This interaction may help explain constipation, bloating, early satiety, abdominal discomfort, nausea, and other gastrointestinal symptoms that occur in some patients with Lyme disease, even when imaging, endoscopy, and routine laboratory testing are normal.
A more detailed discussion of these manifestations is available in Gastrointestinal Dysregulation in Lyme Disease.
Can immune dysregulation be treated?
There is no single treatment that specifically reverses immune dysregulation. Management depends on the individual’s clinical presentation and the underlying mechanisms contributing to persistent symptoms.
When active Lyme disease or another tick-borne infection is present, appropriate antimicrobial therapy remains an important consideration. In other patients, treatment may focus on improving sleep, optimizing autonomic function, reducing pain amplification, addressing nutritional deficiencies, treating coexisting medical conditions, and gradually restoring physical conditioning.
Research continues to investigate therapies that target abnormal immune regulation, neuroinflammation, and autonomic dysfunction. At present, treatment should be individualized rather than based on a single proposed mechanism.
How immune dysregulation relates to PTLDS
Post-Treatment Lyme Disease Syndrome (PTLDS) describes a clinical pattern of persistent symptoms following standard Lyme disease treatment. Immune dysregulation provides one biologically plausible framework for understanding these persistent symptoms.
In some patients, immune and nervous system regulation may fail to fully reset after infection. In others, clinicians and researchers continue to investigate whether persistent Borrelia burgdorferi infection, other tick-borne coinfections, persistent antigenic stimulation, tissue injury, autonomic dysfunction, central sensitization, or combinations of these mechanisms contribute to ongoing illness. These possibilities are not necessarily mutually exclusive and may differ among patients.
A broader discussion of this clinical syndrome is available in Post-Treatment Lyme Disease Syndrome (PTLDS).
Why this framework matters clinically
Recognizing immune dysregulation as one potential contributor to persistent symptoms can help explain why patients experience multisystem illness despite normal routine testing. It also provides a framework that integrates neurologic, autonomic, and immune processes rather than viewing each symptom in isolation.
At the same time, clinicians should avoid assuming that immune dysregulation explains every persistent symptom. Continued evaluation for active tick-borne infection, reinfection, coinfections, medication effects, and unrelated medical conditions remains an important part of comprehensive care.
Frequently Asked Questions
Is immune dysregulation the same as autoimmune disease?
No. Immune dysregulation refers to altered immune signaling and regulation. It does not require autoantibodies or meet diagnostic criteria for autoimmune disease, although autoimmune disorders and immune dysregulation may coexist in some patients.
Can immune dysregulation improve over time?
Yes. In many patients, immune and neuroimmune regulation gradually improve over time, although recovery varies considerably between individuals and depends on the underlying contributors to persistent illness.
Why are tests often normal if immune dysregulation is present?
Many immune processes occur at the cellular or signaling level and may not be detected by routine blood tests. Immune activity may also fluctuate over time or occur primarily within tissues rather than in the bloodstream.
Does immune dysregulation mean the infection is still active?
No. Immune dysregulation by itself does not prove that infection persists. It is one proposed mechanism for persistent symptoms after Lyme disease. Researchers continue to investigate whether persistent Borrelia burgdorferi infection, other tick-borne coinfections, immune dysregulation, persistent antigenic stimulation, or combinations of these mechanisms contribute to ongoing illness in different groups of patients.
Does Lyme disease weaken your immune system?
Not necessarily. Most patients with Lyme disease are not immunocompromised. Current evidence suggests Lyme disease does not simply weaken the immune system. Instead, it may alter immune regulation in some patients, leading to persistent inflammatory signaling and neuroimmune dysfunction rather than generalized immune suppression.
Is Lyme disease an autoimmune disease?
No. Lyme disease is an infection caused by Borrelia burgdorferi. Although immune dysregulation and, in some cases, autoimmune mechanisms have been proposed to contribute to persistent symptoms, Lyme disease itself is not classified as an autoimmune disease.
Clinical Takeaway
Immune dysregulation provides one important framework for understanding persistent symptoms after Lyme disease. Altered immune signaling may contribute to neuroinflammation, autonomic dysfunction, pain amplification, fatigue, cognitive impairment, sleep disturbance, and gastrointestinal symptoms without necessarily indicating irreversible tissue injury.
Persistent symptoms, however, are unlikely to arise from a single mechanism in every patient. Ongoing research continues to examine the relative contributions of immune dysregulation, persistent Borrelia burgdorferi infection, other tick-borne coinfections, persistent antigenic stimulation, central sensitization, autonomic dysfunction, and other biologic processes. Careful clinical evaluation remains essential to determine the most appropriate diagnostic and therapeutic approach for each individual.
Understanding immune dysregulation broadens the framework for persistent Lyme disease symptoms while recognizing that multiple biologic mechanisms may coexist and require individualized evaluation.
Related Articles
Persistent Lyme Disease: Clinical Overview
Lyme Disease Symptoms Guide
Lyme Disease Misdiagnosis
Recovery from Lyme Disease
Tick-Borne Coinfections
References
- Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning. Clinical Infectious Diseases. 2013;57(3):333–340.
- Irwin MR. Sleep and inflammation: partners in sickness and in health. Nature Reviews Immunology. 2019.
- Fallon BA, Nields JA, Burrascano JJ, Liegner K, DelBene D, Liebowitz MR. The neuropsychiatric manifestations of Lyme borreliosis. Psychiatric Quarterly. 1992;63(1):95–117.
- Adler BL, et al. Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome? Frontiers in Neurology. 2024.
- Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clinic Proceedings. 1993;68(10):988–1001.
- Pine K, Pine V, Negrut N, Ferician A, Marian P. Infection-Triggered Immune Dysregulation and Immunopathology in Lyme Disease: Mechanisms and Clinical Implications. Journal of Clinical Medicine. 2026;15(8):2922.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
